Literature DB >> 10386583

Isoforms of cytochrome P450 on organic nitrate-derived nitric oxide release in human heart vessels.

Y Minamiyama1, S Takemura, T Akiyama, S Imaoka, M Inoue, Y Funae, S Okada.   

Abstract

Glutathione S-transferases and the cytochrome P450 system have been proposed for the vascular biotransformation systems in the metabolic activation of organic nitrates. The present study was designed to elucidate the role of human cytochrome P450 isoforms on nitric oxide formation from organic nitrates using lymphoblast microsomes transfected with human CYP isoforms cDNA. CYP3A4-transfected microsomes had the most effective potential of nitric oxide formation from isosorbide dinitrate. Anti-CYP3A2 antibody (which cross-reacts with CYP3A4) or ketoconazole (an inhibitor of the CYP3A superfamily) inhibited nitric oxide formation from isosorbide dinitrate in rat heart microsomes. Immunohistochemistry of human heart also showed intense bindings of CYP3A4 antibody in the endothelium of the endocardium and coronary vessels. These results suggest that the CYP3A4-NADPH-cytochrome P450 reductase system specifically participates in nitric oxide formation from isosorbide dinitrate.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10386583     DOI: 10.1016/s0014-5793(99)00612-2

Source DB:  PubMed          Journal:  FEBS Lett        ISSN: 0014-5793            Impact factor:   4.124


  16 in total

1.  Number of nitrate groups determines reactivity and potency of organic nitrates: a proof of concept study in ALDH-2-/- mice.

Authors:  P Wenzel; U Hink; M Oelze; A Seeling; T Isse; K Bruns; L Steinhoff; M Brandt; A L Kleschyov; E Schulz; K Lange; H Weiner; J Lehmann; K J Lackner; T Kawamoto; T Münzel; A Daiber
Journal:  Br J Pharmacol       Date:  2007-01-15       Impact factor: 8.739

2.  Impaired vasodilator response to organic nitrates in isolated basilar arteries.

Authors:  D Martens; G Kojda
Journal:  Br J Pharmacol       Date:  2001-01       Impact factor: 8.739

3.  Mechanisms of nitric oxide generation from nitroglycerin and endogenous sources during hypoxia in vivo.

Authors:  Per Agvald; L Christofer Adding; Andreas Artlich; Magnus G Persson; Lars E Gustafsson
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

4.  Direct gas measurements indicate that the novel cyclooxygenase inhibitor AZD3582 is an effective nitric oxide donor in vivo.

Authors:  L Christofer Adding; Per Agvald; Lars I Andersson; Bror Jonzon; Janet Hoogstraate; Lars E Gustafsson
Journal:  Br J Pharmacol       Date:  2005-07       Impact factor: 8.739

5.  Various intracellular compartments cooperate in the release of nitric oxide from glycerol trinitrate in liver.

Authors:  Andrey V Kozlov; Barbara Dietrich; Hans Nohl
Journal:  Br J Pharmacol       Date:  2003-07       Impact factor: 8.739

6.  Effect of oral organic nitrates on expression and activity of vascular soluble guanylyl cyclase.

Authors:  M Oppermann; V T-V Dao; T Suvorava; M Bas; G Kojda
Journal:  Br J Pharmacol       Date:  2008-06-30       Impact factor: 8.739

Review 7.  Organic nitrate metabolism and action: toward a unifying hypothesis and the future-a dedication to Professor Leslie Z. Benet.

Authors:  Nathaniel A Page; Ho-Leung Fung
Journal:  J Pharm Sci       Date:  2013-05-13       Impact factor: 3.534

Review 8.  Organic Nitrate Therapy, Nitrate Tolerance, and Nitrate-Induced Endothelial Dysfunction: Emphasis on Redox Biology and Oxidative Stress.

Authors:  Andreas Daiber; Thomas Münzel
Journal:  Antioxid Redox Signal       Date:  2015-09-24       Impact factor: 8.401

9.  Determination of the dominant arachidonic acid cytochrome p450 monooxygenases in rat heart, lung, kidney, and liver: protein expression and metabolite kinetics.

Authors:  Ahmed A El-Sherbeni; Mona E Aboutabl; Beshay N M Zordoky; Anwar Anwar-Mohamed; Ayman O S El-Kadi
Journal:  AAPS J       Date:  2012-11-10       Impact factor: 4.009

Review 10.  Prodrugs of nonsteroidal anti-inflammatory drugs (NSAIDs), more than meets the eye: a critical review.

Authors:  Amjad M Qandil
Journal:  Int J Mol Sci       Date:  2012-12-17       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.